Lfcin B (20-25)-Arenicin-3 [G1,12A; Y5N; Y17H], B6N2
General Information
DRACP ID DRACP04066
Peptide Name Lfcin B (20-25)-Arenicin-3 [G1,12A; Y5N; Y17H], B6N2
Sequence RRWQWRAFCWNVCVYRNAVRVCHRRCN
Sequence Length 27
UniProt ID A0A3F2YLM5
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C154H233N57O33S4
Absent amino acids DEGIKLMPST
Common amino acids R
Mass 400308
Pl 11.74
Basic residues 8
Acidic residues 0
Hydrophobic residues 10
Net charge 8
Boman Index -9983
Hydrophobicity -72.22
Aliphatic Index 50.37
Half Life
Mammalian: 5.5 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 18240
Absorbance 280nm 701.54
Polar residues 8
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 29329001
Title Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin6/Tat11
Doi Not available
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 16573